期刊文献+

肝胆管结石合并胆管癌的诊断及治疗体会 被引量:8

Experience of diagnosis and treatment about bile duct stone combined cholangiocarcinoma
下载PDF
导出
摘要 目的探讨肝胆管结石合并胆管癌的诊断及治疗要点。方法对36例诊断为肝胆管结石合并胆管癌患者的临床资料进行回顾性分析。结果肝胆管结石合并胆管癌患者占肝胆管结石患者的5.3%,其临床表现主要以右上腹疼痛及反复的胆管炎发作为主,但缺乏特异性。术前胆管癌组患者AKP、γ-GT均不同程度升高,ALT升高32例,总胆红素升高14例,与非胆管癌组相比,AKP、γ-GT、ALT、TBIL均显著升高(P<0.01),且胆管癌组术前血CA19-9及CEA显著高于非胆管癌组(P<0.01),而CA125及AFP在两组间无显著差异(P>0.05)。手术后随访显示,行根治性手术的患者中位生存期为28个月,姑息性手术治疗的患者中位生存期为11个月,显著低于根治性手术患者(P<0.05),行根治性手术治疗的患者第1、2、3年生存率均显著高于姑息性治疗的患者(P<0.05)。结论肝胆管结石合并胆管癌的临床表现缺乏特异性,对有肝内占位、血CA19-9及CEA显著升高者应行病例活检确诊,并积极的行根治性手术治疗,从而有助于提高患者的生存期。 Objective To investigate the points of diagnosis and treatment of the bile duct stones combined cholangiocar- cinoma. Methods The clinical data of 36 cases diagnosed as bile duct stone with cholangiocarcinoma were analyzed retro- spectively. Results The rate of bile duct stones with cholangiocarcinoma accounted for 5.3%, the main clinical manifesta- tions were right upper quadrant pain and repeated cholangitis, but which was the lack of specificity. AKP, ~/-GT, ALT, TBIL in cancer group increased significantly compared with that in non-cancer group (P 〈 0.01), including 32 cases with ALT increase and 14 cases with the total bilirubin increase, and serum CA19-9 and CEA in cancer group were signifi- cantly higher than that in non-cancer group (P 〈 0.01), while CA125 and AFP had no significant difference between the two groups (P 〉 0.05). Post-operative follow-up show, line radical surgery patients-bit survival of 28 months, palliative surgical treatment of patients median survival was 11 months, which was significantly less than radical surgery patients (P 〈 0.05), and 1, 2 and 3 year survival rates of patients-line radical surgery were significantly higher than the patients with the palliative treatment (P 〈 0.05). Conclusion The clinical manifestations of bile duct stones combined cholangiocarcinoma is lack of specificity. For patients with intrahepatic or blood CA19-9 and CEA increasing should be confirmed by biopsy, and radical surgery patients should be done,which help to improve the survival of patients.
作者 万拥军
出处 《中国现代医生》 2012年第18期150-151,共2页 China Modern Doctor
关键词 肝胆管结石 胆管癌 诊断 Bile duct stones Cholangiocarcinoma Diagnosis
  • 相关文献

参考文献4

二级参考文献24

  • 1孙晓伟,王霄英,邹英华,蒋学祥.梗阻性黄疸患者MRCP及肝胆断层MR检查对于PTC及PTBD指导作用的分析[J].中国医学影像技术,2005,21(3):375-377. 被引量:8
  • 2胡建苏,颜小玲,林晓丹.B超结合CT在肝胆管结石并肝胆管癌诊断中应用[J].肝胆外科杂志,2006,14(3):218-219. 被引量:2
  • 3沈小健,龚建平,蔡庆,付冬,沈玉英,徐建良,钱铭辉.多层螺旋CT胆管MPR与MRCP的初步对照研究[J].实用放射学杂志,2006,22(11):1358-1361. 被引量:7
  • 4Kim YT,Byun JS,Kim J,et al.Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis[J].Hepatogastroenterology,2003,50(49):8-12.
  • 5Strong RW,Chew SP,Wall DR,et al.Liver transplantation for hepatolithiasis[J].Asian J Surg,2002,25(2):180-183.
  • 6Francesco Donato,Umberto Gelatti,Alessandro Tagger,Maurizio Favret,Maria Lisa Ribero,Francesco Callea,Claudia Martelli,Antonella Savio,Paola Trevisi,Giuseppe Nardi.Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case–control study in Italy[J].Cancer Causes and Control.2001(10)
  • 7Tomonori Shimonishi,Motoko Sasaki,Yasuni Nakanuma.Precancerous lesions of intrahepatic cholangiocarcinoma[J].Journal of Hepato - Biliary - Pancreatic Surgery.2000(6)
  • 8Tadashi Terada,Yasuni Nakanuma.Cell kinetic analyses and expression of carcinoembryonic antigen, carbohydrate antigen 19-9 and DU-PAN-2 in hyperplastic, pre-neoplastic and neoplastic lesions of intrahepatic bile ducts in livers with hepatoliths[J].Virchows Archiv A Pathological Anatomy and Histopathology.1992(4)
  • 9Khan SA,Thomas HC,Davidson BR,Taylor-Robinson SD.Cholangiocarcinoma[].Lancet.2005
  • 10Shin HR,Lee CU,Park HJ,Seol SY,Chung JM,Choi HC,Ahn YO,Shigemastu T.Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea[].Int J Epidemiol.1996

共引文献74

同被引文献1659

引证文献8

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部